SEC Tracker
Get the app

Hims & Hers Health HIMS

Hims & Hers Health Q3 FY25: revenue $599.0M, up 49%; diluted EPS $0.06

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Hims & Hers Health reported for Q3 FY25, the quarter ended Sep 30, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$599.0M+49% from $401.6M in Q3 FY2410-Q income statement, on EDGAR
  2. Net income$15.8M−79% from $75.6M in Q3 FY2410-Q income statement, on EDGAR
  3. Diluted EPS$0.06−81% from $0.32 in Q3 FY2410-Q income statement, on EDGAR
  4. Cash and cash equivalents$345.8M+109% from $165.5M in Q3 FY24Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations$148.7M+74% from $85.3M in Q3 FY2410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Hims & Hers Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8011 and related industry codes: the same peer list as the financial tables.

  1. Teladoc Health TDOC public float $1.5B, Jun 30, 2025
  2. LifeMD LFMD public float $512M, Jun 30, 2025
  3. Starling Oncology TOI public float $137M, Jun 30, 2025
  4. Airsculpt Technologies AIRS public float $80M, Jun 30, 2025
  5. SBC Medical Group Holdings SBC public float $48M, Jun 30, 2025